Companion Diagnostics Market Grow at a CAGR of 15.4% till 2023 | Global Opportunity with Focus on Emerging Technologies and Trends

Companion Diagnostics Market are used to determine which patients are benefited from a certain type of medication or which therapies are best suited for the patients with certain medical conditions. Companion diagnostics involves tests and devices or tools which provide information about the safe and effective use of the specific therapeutic product. It not only provides information about the efficacy of the drugs but also the side effects that are associated with the drug.

Abbott (U.S.), Agilent Technologies (U.S.), ARUP Laboratories (U.S.), F. Hoffmann-La Roche AG. (Germany), Myriad Genetics Inc. (U.S.), QIAGEN N.V. (Germany), and Thermo Fisher Scientific Inc. (U.S.). and others are some of the prominent players at the forefront of competition in the global companion diagnostics market and are profiled in MRFR Analysis.

Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/3077

Companion Diagnostics is the as a bio-analytical method designed for the assessment of the patient to check whether patient responds to a specific medical treatment or not. Global companion diagnostics market is expected to grow at a CAGR of 15.4% during forecasted period 2017-2023.

Industry Updates

December, 2016 Agilent Technologies announced the acquisition of Multiplicom N.V., a Leading European Diagnostics Company. The acquisition of Multiplicom significantly strengthens our presence in the genomics market

August, 2016 Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.

May, 2016 Myriad completes acquisition of Sividon Diagnostics. With this deal, company believes to strengthen its market leading oncology portfolio of high value personalized medicine products.

April, 2016 Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

August 2015 Roche Holdsing AG Roche acquires GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholdsers $190 million upfront and up to $235 million in contingent product related milestones.

global companion diagnostics market has been segmented on the basis of technology which comprises of Polymerase chain reaction (PCR), In-situ hybridization, and immunohistochemistry. On the basis of application, market is segmented into cancer, infectious diseases, cardiovascular diseases, CNS diseases, and others. On the basis of end user, market is segmented into pharmaceutical & biotech companies, clinical laboratories, CRO, and other.

Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/companion-diagnostic-market-3077

Geographically, The Market, by region, has been segmented into North America, Latin America, Europe, Middle East & Africa, and Asia Pacific.

Moreover, a number of CDx initiatives, research & development programs, product launch and diagnostic tools have emerged and lot many are still in the pipeline. The U.S. has gained significant pharmaceutical developments along with FDA approvals; patents and licensing that enable it to position itself in the global companion diagnostic market.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.